InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Prentiss Christopher B, 首席财务官. Officer active across 3 companies, notably Adamas Pharmaceuticals Inc. Aggregated, 9 reports have been recorded. Activity tracked since 24 November 2021. The latest transaction was filed on 15 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Prentiss Christopher B is Directeur Financier. He has 9 filings in total, and in the sampled recent filings, the activity runs from 2021-11-24 to 2026-07-17, with a total buy amount of EUR 0 and a total sell amount of EUR 0. The modal transaction nature is Attribution, and the companies mentioned are Mannkind CORP, MANNKIND CORP, and Adamas Pharmaceuticals Inc.